Loading...
XNAS
SLSN
Market cap48mUSD
Jul 09, Last price  
0.70USD
1D
-0.53%
1Q
-37.27%
Jan 2017
-3.29%
Name

Nanophase Technologies Corp

Chart & Performance

D1W1MN
XNAS:SLSN chart
P/E
27.27
P/S
0.79
EPS
0.03
Div Yield, %
Shrs. gr., 5y
13.72%
Rev. gr., 5y
29.37%
Revenues
62m
+18.56%
8,990,83812,209,10810,213,8176,320,3269,461,1849,650,78710,036,7059,589,6939,935,82210,313,18910,782,54712,470,95514,192,53112,508,77517,123,60729,475,00037,317,00037,297,00052,347,00062,064,000
Net income
2m
-57.73%
-5,177,830-3,591,170-6,437,847-4,889,343-4,077,854-3,363,537-2,392,574-2,478,220-1,726,812-1,192,449-1,283,098-788,967-2,080,901-3,006,000989,0002,320,000-2,623,000-4,390,0004,235,0001,790,000
CFO
-9m
L
-3,186,096-1,637,751-2,560,783-3,614,979-1,446,882-2,915,600-599,504-522,000-1,181,000-240,000-241,000-960,000-1,342,000-2,776,000-2,061,0002,321,000-1,650,000-2,006,0001,971,000-8,567,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Nanophase Technologies Corporation, operating within the United States, focuses on the creation, development, and large-scale production of advanced materials, leveraging a comprehensive suite of integrated technologies. The company provides specialized surface-engineered zinc oxide and titanium dioxide, which are key ingredients in sunscreens and various personal care products. Furthermore, they offer a complete range of cosmetics, sun care, and skin care products distributed under their proprietary Solésence brand. Beyond personal care, Nanophase supplies high-performance materials for diverse applications, including architectural and industrial coatings, additives for enhancing abrasion resistance in plastics, components for medical diagnostics, and a variety of surface finishing technologies. Founded in 1989, Nanophase Technologies Corporation is headquartered in Romeoville, Illinois.
IPO date
Nov 28, 1997
Employees
82
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT